Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Age-standardized mortality rates related to viral hepatitis in Brazil

Authors: Hugo Perazzo, Antonio G Pacheco, Paula M Luz, Rodolfo Castro, Chris Hyde, Juliana Fittipaldi, Caroline Rigolon, Sandra W Cardoso, Beatriz Grinsztejn, Valdiléa G Veloso

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Liver-related mortality has been increasing worldwide. We aimed to estimate the age-standardized mortality rates from viral hepatitis in Brazil.

Methods

The Brazilian National Death Registry was analyzed from 2008 to 2014. Viral hepatitis deaths were defined by the following ICD-10 codes in the death certificate: hepatitis A [B15.0; B15.9]; hepatitis B [B16.2; B16.9; B18.1]; hepatitis C [B17.1; B18.2]; hepatitis Delta [B16.0; B16.1; B18.0; B17.0] and other viral hepatitis [B17.2; B17.8; B18.8; B18.9; B19.0; B19.9]. Crude mortality rates were calculated by the ratio between total number of deaths and estimated population. Mortality rates were age-standardized by the direct method using the WHO standard population.

Results

Thirty four thousand ,nine hundred seventy eight deaths had viral hepatitis mentioned in their death certificate [65% male, aged 58 years, 73% associated with hepatitis C]. Age-standardized mortality rate (95% CI) due to viral hepatitis was 2.695 (2.667–2.724) deaths per 100,000 inhabitants: South region had the higher rates [3.997 (3.911–4.085)]. Mortality rates associated with hepatitis A and Delta were 0.032 (0.029–0.035) and 0.028 (0.025–0.031), respectively. Hepatitis C mortality rates were 4-fold higher than those associated with hepatitis B [1.964 (1.940–1.989) vs 0.500 (0.488–0.512)]. South region had the higher rates for hepatitis C [3.163 (3.087–3.241)] and North had the higher rates for hepatitis A [0.066 (0.049–0.087)], B [0.986 (0.918–1.058)] and Delta [0.220 (0.190–0.253)].

Conclusion

Viral hepatitis remains a major public health issue in Brazil. Mortality rates were not homogeneous across the country, suggesting that health policies should be customized according to geographical location.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–128.CrossRefPubMed Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–128.CrossRefPubMed
2.
go back to reference Mendez-Sanchez N, Villa AR, Chavez-Tapia NC, Ponciano-Rodriguez G, Almeda-Valdes P, Gonzalez D, Uribe M. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol. 2005;4:52–5.PubMed Mendez-Sanchez N, Villa AR, Chavez-Tapia NC, Ponciano-Rodriguez G, Almeda-Valdes P, Gonzalez D, Uribe M. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol. 2005;4:52–5.PubMed
3.
go back to reference Ferrarese A, Zanetto A, Gambato M, Bortoluzzi I, Nadal E, Germani G, Senzolo M, Burra P, Russo FP. Liver transplantation for viral hepatitis in 2015. World J Gastroenterol. 2016;22:1570–81.CrossRefPubMedPubMedCentral Ferrarese A, Zanetto A, Gambato M, Bortoluzzi I, Nadal E, Germani G, Senzolo M, Burra P, Russo FP. Liver transplantation for viral hepatitis in 2015. World J Gastroenterol. 2016;22:1570–81.CrossRefPubMedPubMedCentral
4.
go back to reference Aggarwal R, Goel A. Hepatitis a: epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015;28:488–96.CrossRefPubMed Aggarwal R, Goel A. Hepatitis a: epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015;28:488–96.CrossRefPubMed
5.
go back to reference Blasco-Perrin H, Abravanel F, Blasco-Baque V, Peron JM. Hepatitis E, the neglected one. Liver Int. 2016;36(Suppl 1):130–4.CrossRefPubMed Blasco-Perrin H, Abravanel F, Blasco-Baque V, Peron JM. Hepatitis E, the neglected one. Liver Int. 2016;36(Suppl 1):130–4.CrossRefPubMed
6.
go back to reference Brasil. Epidemiological Report of Viral Hepatitis [Boletim Epidemiológico de Hepatites Virais]. Brasília, Brazil: Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2015. Brasil. Epidemiological Report of Viral Hepatitis [Boletim Epidemiológico de Hepatites Virais]. Brasília, Brazil: Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2015.
7.
go back to reference Mesquita F, Santos ME, Benzaken A, Correa RG, Cattapan E, Sereno LS, Naveira MC. The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy. BMC Public Health. 2016;16:1132.CrossRefPubMedPubMedCentral Mesquita F, Santos ME, Benzaken A, Correa RG, Cattapan E, Sereno LS, Naveira MC. The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy. BMC Public Health. 2016;16:1132.CrossRefPubMedPubMedCentral
8.
go back to reference Braga WS, de Oliveira CM, de Araujo JR, Castilho Mda C, Rocha JM, Gimaque JB, Silva ML, Vasconcelos HL, Ramasawmy R, Parana R. Chronic HDV/HBV co-infection: predictors of disease stage---a case series of HDV-3 patients. J Hepatol. 2014;61:1205–11.CrossRefPubMed Braga WS, de Oliveira CM, de Araujo JR, Castilho Mda C, Rocha JM, Gimaque JB, Silva ML, Vasconcelos HL, Ramasawmy R, Parana R. Chronic HDV/HBV co-infection: predictors of disease stage---a case series of HDV-3 patients. J Hepatol. 2014;61:1205–11.CrossRefPubMed
9.
go back to reference Couto I, Victoria M, Veloso VG, Rodrigues L, Grinsztejn B, Lacerda M, Victoria F, Perazzo H. Prevalence and predictors for compensated advanced chronic liver disease (c-ACLD) in patients with chronic Hepatitis Delta virus (HDV) infection. PLoS One. 2017;12:e0174453.CrossRefPubMedPubMedCentral Couto I, Victoria M, Veloso VG, Rodrigues L, Grinsztejn B, Lacerda M, Victoria F, Perazzo H. Prevalence and predictors for compensated advanced chronic liver disease (c-ACLD) in patients with chronic Hepatitis Delta virus (HDV) infection. PLoS One. 2017;12:e0174453.CrossRefPubMedPubMedCentral
10.
11.
go back to reference Perazzo H, Pacheco AG, De Boni R, Luz P, Fittipaldi J, Cardoso S, Grinsztejn B, Veloso V. Age-standardized mortality rates related to cirrhosis in Brazil from 2000 to 2012: a nationwide analysis. Ann Hepatol. 2017(16):269–78. Perazzo H, Pacheco AG, De Boni R, Luz P, Fittipaldi J, Cardoso S, Grinsztejn B, Veloso V. Age-standardized mortality rates related to cirrhosis in Brazil from 2000 to 2012: a nationwide analysis. Ann Hepatol. 2017(16):269–78.
12.
go back to reference Ferreira PR, Brandao-Mello CE, Estes C, Goncales Junior FL, Coelho HS, Razavi H, Cheinquer H, Wolff FH, Ferraz ML, Pessoa MG, et al. Disease burden of chronic hepatitis C in Brazil. Braz J Infect Dis. 2015;19:363–8.CrossRefPubMed Ferreira PR, Brandao-Mello CE, Estes C, Goncales Junior FL, Coelho HS, Razavi H, Cheinquer H, Wolff FH, Ferraz ML, Pessoa MG, et al. Disease burden of chronic hepatitis C in Brazil. Braz J Infect Dis. 2015;19:363–8.CrossRefPubMed
13.
go back to reference Brasil. Guideline for information of cause of death in the death certificate [Manual de instruções para o preenchimento da declaração de obito]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2001. Brasil. Guideline for information of cause of death in the death certificate [Manual de instruções para o preenchimento da declaração de obito]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2001.
16.
go back to reference Vitral CL, Gaspar AM, Souto FJ. Epidemiological pattern and mortality rates for hepatitis a in Brazil, 1980-2002--a review. Mem Inst Oswaldo Cruz. 2006;101:119–27.CrossRefPubMed Vitral CL, Gaspar AM, Souto FJ. Epidemiological pattern and mortality rates for hepatitis a in Brazil, 1980-2002--a review. Mem Inst Oswaldo Cruz. 2006;101:119–27.CrossRefPubMed
17.
go back to reference Zago-Gomes MP, Stantolin GC, Perazzio S, Aikawa KH, Goncalves CS, Pereira FE. Prevalence of anti-hepatits a antibodies in children of different socioeconomic conditions in Vila Velha, ES. Rev Soc Bras Med Trop. 2005;38:285–9.CrossRefPubMed Zago-Gomes MP, Stantolin GC, Perazzio S, Aikawa KH, Goncalves CS, Pereira FE. Prevalence of anti-hepatits a antibodies in children of different socioeconomic conditions in Vila Velha, ES. Rev Soc Bras Med Trop. 2005;38:285–9.CrossRefPubMed
18.
go back to reference Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546–55.CrossRefPubMed Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546–55.CrossRefPubMed
19.
go back to reference Viana S, Parana R, Moreira RC, Compri AP, Macedo V. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg. 2005;73:808–14.PubMed Viana S, Parana R, Moreira RC, Compri AP, Macedo V. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg. 2005;73:808–14.PubMed
20.
go back to reference Souto FJ. Distribution of hepatitis B infection in Brazil: the epidemiological situation at the beginning of the 21 st century. Rev Soc Bras Med Trop. 2016;49:11–23.CrossRefPubMed Souto FJ. Distribution of hepatitis B infection in Brazil: the epidemiological situation at the beginning of the 21 st century. Rev Soc Bras Med Trop. 2016;49:11–23.CrossRefPubMed
21.
go back to reference Pinto FP, Ferreira OC Jr, Olmedo DB, Precioso PM, Barquette FR, Castilho MC, Silva SG, Porto LC. Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study. Ann Hepatol. 2015;14:815–25.CrossRefPubMed Pinto FP, Ferreira OC Jr, Olmedo DB, Precioso PM, Barquette FR, Castilho MC, Silva SG, Porto LC. Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study. Ann Hepatol. 2015;14:815–25.CrossRefPubMed
22.
go back to reference Pereira LM, Martelli CM, Moreira RC, Merchan-Hamman E, Stein AT, Cardoso MR, Figueiredo GM, Montarroyos UR, Braga C, Turchi MD, et al. Prevalence and risk factors of hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infect Dis. 2013;13:60.CrossRefPubMedPubMedCentral Pereira LM, Martelli CM, Moreira RC, Merchan-Hamman E, Stein AT, Cardoso MR, Figueiredo GM, Montarroyos UR, Braga C, Turchi MD, et al. Prevalence and risk factors of hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infect Dis. 2013;13:60.CrossRefPubMedPubMedCentral
24.
go back to reference Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386:743–800.CrossRefPubMedCentral Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386:743–800.CrossRefPubMedCentral
26.
go back to reference Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156:271–8.CrossRefPubMed Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156:271–8.CrossRefPubMed
27.
go back to reference Younossi ZM, Otgonsuren M, Henry L, Arsalla Z, Stepnaova M, Mishra A, Venkatesan C, Hunt S. Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States. J Viral Hepat. 2015;22:137–45.CrossRefPubMed Younossi ZM, Otgonsuren M, Henry L, Arsalla Z, Stepnaova M, Mishra A, Venkatesan C, Hunt S. Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States. J Viral Hepat. 2015;22:137–45.CrossRefPubMed
28.
go back to reference GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-limita specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–71.CrossRef GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-limita specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–71.CrossRef
29.
go back to reference Victora CG. Barreto ML, do Carmo Leal M, Monteiro CA, Schmidt MI, Paim J, Bastos FI, Almeida C, Bahia L, Travassos C et al: health conditions and health-policy innovations in Brazil: the way forward. Lancet. 2011;377:2042–53.CrossRefPubMed Victora CG. Barreto ML, do Carmo Leal M, Monteiro CA, Schmidt MI, Paim J, Bastos FI, Almeida C, Bahia L, Travassos C et al: health conditions and health-policy innovations in Brazil: the way forward. Lancet. 2011;377:2042–53.CrossRefPubMed
30.
go back to reference Hanus JS, Ceretta LB, Simoes PW, Tuon L. Incidence of hepatitis C in Brazil. Rev Soc Bras Med Trop. 2015;48:665–73.CrossRefPubMed Hanus JS, Ceretta LB, Simoes PW, Tuon L. Incidence of hepatitis C in Brazil. Rev Soc Bras Med Trop. 2015;48:665–73.CrossRefPubMed
31.
go back to reference Oliveira Mde L, Bastos FI, Telles PR, Hacker Mde A, Oliveira SA, Miguel JC, Yoshida CF. Epidemiological and genetic analyses of hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil. J Clin Virol. 2009;44:200–6.CrossRefPubMed Oliveira Mde L, Bastos FI, Telles PR, Hacker Mde A, Oliveira SA, Miguel JC, Yoshida CF. Epidemiological and genetic analyses of hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil. J Clin Virol. 2009;44:200–6.CrossRefPubMed
32.
go back to reference Crispim MA, Fraiji NA, Campello SC, Schriefer NA, Stefani MM, Kiesslich D. Molecular epidemiology of hepatitis B and hepatitis delta viruses circulating in the western Amazon region. North Brazil BMC Infect Dis. 2014;14:94.CrossRefPubMed Crispim MA, Fraiji NA, Campello SC, Schriefer NA, Stefani MM, Kiesslich D. Molecular epidemiology of hepatitis B and hepatitis delta viruses circulating in the western Amazon region. North Brazil BMC Infect Dis. 2014;14:94.CrossRefPubMed
33.
go back to reference Cruz HM, Scalioni Lde P, de Paula VS, da Silva EF, do OK MFA, Cruz MS, Bastos FI, Pollo-Flores P, Leal E, et al. Evaluating HBsAg rapid test performance for different biological samples from low and high infection rate settings & populations. BMC Infect Dis. 2015;15:548.CrossRefPubMedPubMedCentral Cruz HM, Scalioni Lde P, de Paula VS, da Silva EF, do OK MFA, Cruz MS, Bastos FI, Pollo-Flores P, Leal E, et al. Evaluating HBsAg rapid test performance for different biological samples from low and high infection rate settings & populations. BMC Infect Dis. 2015;15:548.CrossRefPubMedPubMedCentral
34.
go back to reference Barata RB, Ribeiro MC, de Moraes JC, Flannery B. Socioeconomic inequalities and vaccination coverage: results of an immunisation coverage survey in 27 Brazilian capitals, 2007-2008. J Epidemiol Community Health. 2012;66:934–41.CrossRefPubMedPubMedCentral Barata RB, Ribeiro MC, de Moraes JC, Flannery B. Socioeconomic inequalities and vaccination coverage: results of an immunisation coverage survey in 27 Brazilian capitals, 2007-2008. J Epidemiol Community Health. 2012;66:934–41.CrossRefPubMedPubMedCentral
35.
go back to reference Brasil. Guideline for management and treatment of chronic hepatitis B and its co-infections [Protocolo Clinico e Diretrizes Terapêuticas para Tratamento da Hepatite Viral Crônica B e co-infecções]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2014. Brasil. Guideline for management and treatment of chronic hepatitis B and its co-infections [Protocolo Clinico e Diretrizes Terapêuticas para Tratamento da Hepatite Viral Crônica B e co-infecções]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2014.
36.
go back to reference Castro R, Perazzo H, Grinsztejn B, Veloso VG, Hyde C. Chronic hepatitis C: an overview of evidence on epidemiology and management from a Brazilian perspective. Int J Hepatol. 2015;2015:852968.CrossRefPubMedPubMedCentral Castro R, Perazzo H, Grinsztejn B, Veloso VG, Hyde C. Chronic hepatitis C: an overview of evidence on epidemiology and management from a Brazilian perspective. Int J Hepatol. 2015;2015:852968.CrossRefPubMedPubMedCentral
37.
go back to reference da Rosa L, Dantas-Correa EB, Narciso-Schiavon JL, Schiavon Lde L. Diagnostic performance of two point-of-care tests for anti-HCV detection. Hepat Mon. 2013;13:e12274.PubMedPubMedCentral da Rosa L, Dantas-Correa EB, Narciso-Schiavon JL, Schiavon Lde L. Diagnostic performance of two point-of-care tests for anti-HCV detection. Hepat Mon. 2013;13:e12274.PubMedPubMedCentral
38.
go back to reference Brasil. The role of hepatic elastography on liver fibrosis staging [Elastografia hepática ultrassônica no diagnóstico da fibrose hepática]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2015. Brasil. The role of hepatic elastography on liver fibrosis staging [Elastografia hepática ultrassônica no diagnóstico da fibrose hepática]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2015.
39.
go back to reference Brasil. Guideline for management and treatment of chronic hepatitis C and its co-infections [Protocolo Clinico e Diretrizes Terapêuticas para Tratamento da Hepatite Viral Crônica C e co-infecções]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2015. Brasil. Guideline for management and treatment of chronic hepatitis C and its co-infections [Protocolo Clinico e Diretrizes Terapêuticas para Tratamento da Hepatite Viral Crônica C e co-infecções]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2015.
40.
go back to reference de Lima EE, Queiroz BL. Evolution of the deaths registry system in Brazil: associations with changes in the mortality profile, under-registration of death counts, and ill-defined causes of death. Cad Saude Publica. 2014;30:1721–30.CrossRefPubMed de Lima EE, Queiroz BL. Evolution of the deaths registry system in Brazil: associations with changes in the mortality profile, under-registration of death counts, and ill-defined causes of death. Cad Saude Publica. 2014;30:1721–30.CrossRefPubMed
41.
go back to reference Franca E, de Abreu DX, Rao C, Lopez AD. Evaluation of cause-of-death statistics for Brazil, 2002-2004. Int J Epidemiol. 2008;37:891–901.CrossRefPubMed Franca E, de Abreu DX, Rao C, Lopez AD. Evaluation of cause-of-death statistics for Brazil, 2002-2004. Int J Epidemiol. 2008;37:891–901.CrossRefPubMed
42.
go back to reference Franca E, Campos D, Guimaraes MD, Souza Mde F. Use of verbal autopsy in a national health information system: effects of the investigation of ill-defined causes of death on proportional mortality due to injury in small municipalities in Brazil. Popul Health Metr. 2011;9:39.CrossRefPubMedPubMedCentral Franca E, Campos D, Guimaraes MD, Souza Mde F. Use of verbal autopsy in a national health information system: effects of the investigation of ill-defined causes of death on proportional mortality due to injury in small municipalities in Brazil. Popul Health Metr. 2011;9:39.CrossRefPubMedPubMedCentral
43.
go back to reference Franca EB, da Cunha CC, Vasconcelos AM, Escalante JJ, de Abreu DX, de Lima RB, de Morais Neto OL. Investigation of ill-defined causes of death: assessment of a program's performance in a state from the northeastern region of Brazil. Rev Bras Epidemiol. 2014;17:119–34.CrossRefPubMed Franca EB, da Cunha CC, Vasconcelos AM, Escalante JJ, de Abreu DX, de Lima RB, de Morais Neto OL. Investigation of ill-defined causes of death: assessment of a program's performance in a state from the northeastern region of Brazil. Rev Bras Epidemiol. 2014;17:119–34.CrossRefPubMed
Metadata
Title
Age-standardized mortality rates related to viral hepatitis in Brazil
Authors
Hugo Perazzo
Antonio G Pacheco
Paula M Luz
Rodolfo Castro
Chris Hyde
Juliana Fittipaldi
Caroline Rigolon
Sandra W Cardoso
Beatriz Grinsztejn
Valdiléa G Veloso
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2619-y

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue